Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212820 | SCV000170862 | benign | not specified | 2014-01-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000212820 | SCV000314376 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Color Diagnostics, |
RCV000127301 | SCV000537407 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000114581 | SCV000784860 | likely benign | Familial cancer of breast | 2017-01-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000114581 | SCV002405532 | benign | Familial cancer of breast | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000212820 | SCV002551640 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000127301 | SCV002747005 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002498484 | SCV002795449 | likely benign | Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3 | 2021-09-08 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149786 | SCV003838081 | likely benign | Breast and/or ovarian cancer | 2022-03-22 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315622 | SCV004016492 | benign | Breast-ovarian cancer, familial, susceptibility to, 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001529642 | SCV005213514 | likely benign | not provided | criteria provided, single submitter | not provided | ||
University of Washington Department of Laboratory Medicine, |
RCV000127301 | SCV000265335 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-01 | no assertion criteria provided | clinical testing | |
Leiden Open Variation Database | RCV000114581 | SCV001193321 | likely benign | Familial cancer of breast | 2019-05-13 | no assertion criteria provided | curation | Curators: Marc Tischkowitz, Arleen D. Auerbach. Submitter to LOVD: Marc Tischkowitz. |
Diagnostic Laboratory, |
RCV001529642 | SCV001743438 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001529642 | SCV001798062 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529642 | SCV001807340 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV001529642 | SCV001905920 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529642 | SCV001928336 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529642 | SCV001959245 | likely benign | not provided | no assertion criteria provided | clinical testing |